A Secondary Analysis of Imatinib Adherence Among Patients with Chronic Myeloid Leukemia
Background: Two recent studies have identified a strong association between treatment adherence and treatment response in patients with chronic myeloid leukemia (CML) treated with imatinib; and suggested a possible 7-10% tolerance margin for nonadherence before impaired treatment response is likely...
| Main Author: | |
|---|---|
| Language: | en |
| Published: |
The University of Arizona.
2010
|
| Online Access: | http://hdl.handle.net/10150/156890 |